Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Gaulin, B. D. Articles by Dufresne, R. L. Search for Related Content PubMed Citation Articles by Gaulin, B. D. Articles by Dufresne, R. L. Other Neuroleptics

Clozapine-Associated Elevation in Serum Triglycerides

OBJECTIVE: This study was conducted to determine serum lipid level changes in patients who received clozapine or haloperidol. METHOD: Medical records of 222 inpatients treated with clozapine or haloperidol were reviewed. Age, weight, gender, daily antipsychotic dose, total cholesterol level, serum triglyceride level, and concurrent medications were recorded. RESULTS: Clozapine-treated men had significantly higher follow-up serum triglyceride concentrations over baseline than did haloperidol-treated men. Female patients experienced serum triglyceride level elevations regardless of antipsychotic treatment. Changes in total cholesterol levels were not significantly different between treatment groups. CONCLUSIONS: An increase in serum triglyceride levels occurred in clozapine-treated patients; screening for serum triglyceride elevations may be warranted before treatment with clozapine.

This article has been cited by other articles:

				J. G. Fiedorowicz, D. A. Solomon, J. Endicott, A. C. Leon, C. Li, J. P. Rice, and W. H. Coryell Manic/Hypomanic Symptom Burden and Cardiovascular Mortality in Bipolar Disorder Psychosom Med, July 1, 2009; 71(6): 598 - 606. [Abstract] [Full Text] [PDF]

				R. L Dufresne Weighing In: Emergent Diabetes Mellitus and Second-Generation Antipsychotics Ann. Pharmacother., October 1, 2007; 41(10): 1725 - 1727. [Abstract] [Full Text] [PDF]

				References PsychiatryOnline CME, May 1, 2007; 2007(1): 2 - 2. [Full Text]

				M. Olfson, S. C. Marcus, P. Corey-Lisle, A.V. Tuomari, P. Hines, and G. J. L'Italien Hyperlipidemia Following Treatment With Antipsychotic Medications Am J Psychiatry, October 1, 2006; 163(10): 1821 - 1825. [Abstract] [Full Text] [PDF]

				R. L. Lindsay, S. Leone, and M. G. Aman Discontinuation of Risperidone and Reversibility of Weight Gain in Children with Disruptive Behavior Disorders Clinical Pediatrics, June 1, 2004; 43(5): 437 - 444. [Abstract] [PDF]

				J. W. Newcomer, D. W. Haupt, R. Fucetola, A. K. Melson, J. A. Schweiger, B. P. Cooper, and G. Selke Abnormalities in Glucose Regulation During Antipsychotic Treatment of Schizophrenia Arch Gen Psychiatry, April 1, 2002; 59(4): 337 - 345. [Abstract] [Full Text] [PDF]

				A. H. Glassman and J. T. Bigger Jr. Antipsychotic Drugs: Prolonged QTc Interval, Torsade de Pointes, and Sudden Death Am J Psychiatry, November 1, 2001; 158(11): 1774 - 1782. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 1999 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us